Literature DB >> 2573544

P-glycoproteins encoded by mdr 1b in murine gravid uterus and multidrug resistant tumor cell lines are differentially glycosylated.

L M Greenberger1, J M Croop, S B Horwitz, R J Arceci.   

Abstract

There are 3 members of the multidrug-resistance gene family expressed in mouse. Only one of these, mdr 1b, and its gene product P-glycoprotein are induced to high levels in the mouse endometrium during pregnancy. It is shown here that P-glycoprotein in the gravid uterus is significantly larger (Mr 155,000) compared to P-glycoprotein encoded by mdr 1b in a murine multidrug-resistant cell line (Mr 140,000). However, both species co-migrate after enzymatic removal of N-linked sugars (Mr 125,000). These results demonstrate that differential glycosylation of the mdr 1b gene product contributes to molecular heterogeneity found in P-glycoprotein from normal and multidrug-resistant cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573544     DOI: 10.1016/0014-5793(89)81586-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Immunohistochemical detection of P-glycoprotein in endometrial adenocarcinoma.

Authors:  C A Axiotis; C Monteagudo; M J Merino; N LaPorte; R D Neumann
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

2.  P-glycoprotein is expressed in parathyroid epithelium and is regulated by calcium.

Authors:  C A Axiotis; D Bani; S Bianchi; P Pioli; A Tanini; M L Brandi
Journal:  Calcif Tissue Int       Date:  1995-02       Impact factor: 4.333

3.  Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells.

Authors:  Donavon C Hiss; Gary A Gabriels; Peter I Folb
Journal:  Cancer Cell Int       Date:  2007-04-18       Impact factor: 5.722

4.  Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies.

Authors:  M A Barrand; P R Twentyman
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.